Master protocol trials in oncology: Review and new trial designs - ScienceDirect
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response | European Respiratory Society
Newsletter DITEP – november 2019 | Gustave Roussy
Rethinking clinical trials for next-generation cancer drugs
Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both | NEJM
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples - Annals of Oncology
Life | Free Full-Text | Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials
Basket trial approach capitalizes on the molecular mechanisms of tumors | PNAS
Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology. - Abstract - Europe PMC
Basket Clinical Trial Designs: The Key to Testing Innovative Therapies is Innovation in Study Design and Conduct - ACRP
Frontiers | Basket Trials for Intractable Cancer
Clinical trial designs for the era of molecular oncology. (a) Umbrella... | Download Scientific Diagram
Study design of the Basket of Baskets trial developed by Cancer Core Europe | Download Scientific Diagram
Basket Trials for Cancer Treatments – Cofactor Genomics
Study design of the Basket of Baskets trial developed by Cancer Core Europe | Download Scientific Diagram
Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples. | Semantic Scholar
Webinar: Key Design Considerations for Basket Trials and Umbrella Trials
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial - The Lancet Oncology
Blog | Lilly TrialGuide
Basket Trials for Cancer Treatments – Cofactor Genomics
Baskets and Umbrellas: Trial Design for Precision Oncology
Basket clinical trial design for targeted therapies for cancer: a French National Authority for Health statement for health technology assessment - The Lancet Oncology
Clinical trial design: Past, present, and future in the context of b
